Efficacy and Safety of Letibotulinumtoxin A in the Treatment of Glabellar Lines: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Phase 3 Study

Abstract Background Letibotulinumtoxin A (Hugel, Inc., Chuncheon, Republic of Korea and CROMA Pharma, Leobendorf, Austria) is a newly manufactured neurotoxin derived from Clostridium botulinum strain CBFC26. Objectives The aim of this study was to assess the efficacy and safety of letibotulinumtoxin...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Aesthetic surgery journal 2022-05, Vol.42 (6), p.677-688
Hauptverfasser:	Mueller, Daniel S, Prinz, Valentina, Adelglass, Jeffrey, Cox, Sue Ellen, Gold, Michael H, Kaufman-Janette, Joely, Nestor, Mark S, Taylor, Susan, Frank, Konstantin
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!